Health and Healthcare

Celgene : CELG

All CELG Articles

433 Articles

Chris Lange | Jul 27, 2016 at 7:50 AM EDT

Major Biotechs See Increased Short Interest Bets

The short interest data are out for the July 15 settlement date. Short interest increased across many of these selected…

Chris Lange | Jul 24, 2016 at 10:12 AM EDT

10 Must-See Earnings for the Coming Week

24/7 Wall St. has put together a preview of Alphabet, Amazon.com, Facebook and some of the other major companies reporting…

Chris Lange | Jul 13, 2016 at 8:10 AM EDT

Short Sellers Become More Selective on Major Biotechs

The June 30 short interest data have been compared with the previous report, and short interest moves were mixed in…

Chris Lange | Jul 12, 2016 at 10:10 AM EDT

Biotechs With Drug Pipelines Closest to Zero Valuation

Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline…

Lee Jackson | Jul 6, 2016 at 9:25 AM EDT

Jefferies Has Top Growth Stocks to Buy for the Rest of 2016

These four top companies are on sale and are very well positioned in their respective sectors. They all look like…

Jon C. Ogg | Jun 28, 2016 at 12:01 PM EDT

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

[cnxvideo id=”655353″ placement=”ros”]Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently…

Chris Lange | Jun 27, 2016 at 7:55 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of…

Lee Jackson | Jun 26, 2016 at 9:48 AM EDT

Large Biotech and Tech Highlight Insider Selling: Applied Materials, Celgene, Cisco Systems, Palo Alto, Delphi and More

What a wild and crazy week for investors. The stock market volatility index jumped up and down as the Brexit decision…

Lee Jackson | Jun 22, 2016 at 8:25 AM EDT

Biotechs Highlight Jefferies 4 Top Growth Stocks to Buy

Now is the time to look for good growth stocks as the second half of the year could have solid…

Chris Lange | Jun 10, 2016 at 8:10 AM EDT

Short Sellers Become More Selective on Major Biotechs

The May 31 short interest data have been compared with the previous report, and short interest moves were mixed in…

Chris Lange | May 25, 2016 at 8:20 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The May 13 short interest data have been compared with the previous report, and short interest moves were mixed in…

Lee Jackson | May 12, 2016 at 8:20 AM EDT

4 Large Cap Growth Stocks to Buy With Incredible 10-Year Track Records

A new JPMorgan research report highlights some large cap secular growth stocks that have shown strong and consistent revenue growth…

Chris Lange | May 11, 2016 at 8:15 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the April 29 settlement date, and short interest moves were mixed in these…

Chris Lange | May 1, 2016 at 10:50 AM EDT

Analysts Make Major Changes to Top Biotech Ratings

With earnings having just been released for some of the top biotech companies, we saw a flurry of analyst calls…

Chris Lange | Apr 27, 2016 at 8:10 AM EDT

Short Sellers Run for Cover From Major Biotechs

The April 15 short interest data have been compared with the previous report, and short interest decreased across the board…

1 … 11 12 13 14 15 … 29

Celgene : CELG

All CELG Articles

Major Biotechs See Increased Short Interest Bets

10 Must-See Earnings for the Coming Week

Short Sellers Become More Selective on Major Biotechs

Biotechs With Drug Pipelines Closest to Zero Valuation

Jefferies Has Top Growth Stocks to Buy for the Rest of 2016

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

Short Sellers Run for Cover From Major Biotechs

Large Biotech and Tech Highlight Insider Selling: Applied Materials, Celgene, Cisco Systems, Palo Alto, Delphi and More

Biotechs Highlight Jefferies 4 Top Growth Stocks to Buy

Short Sellers Become More Selective on Major Biotechs

Short Sellers Grow More Selective on Major Biotechs

4 Large Cap Growth Stocks to Buy With Incredible 10-Year Track Records

Short Sellers Run for Cover From Major Biotechs

Analysts Make Major Changes to Top Biotech Ratings

Short Sellers Run for Cover From Major Biotechs

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

Celgene : CELG

All CELG Articles

Major Biotechs See Increased Short Interest Bets

10 Must-See Earnings for the Coming Week

Short Sellers Become More Selective on Major Biotechs

Biotechs With Drug Pipelines Closest to Zero Valuation

Jefferies Has Top Growth Stocks to Buy for the Rest of 2016

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

Short Sellers Run for Cover From Major Biotechs

Large Biotech and Tech Highlight Insider Selling: Applied Materials, Celgene, Cisco Systems, Palo Alto, Delphi and More

Biotechs Highlight Jefferies 4 Top Growth Stocks to Buy

Short Sellers Become More Selective on Major Biotechs

Short Sellers Grow More Selective on Major Biotechs

4 Large Cap Growth Stocks to Buy With Incredible 10-Year Track Records

Short Sellers Run for Cover From Major Biotechs

Analysts Make Major Changes to Top Biotech Ratings

Short Sellers Run for Cover From Major Biotechs

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Featured Reads

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip